Gsottberger, Franziska http://orcid.org/0000-0003-0911-2204
Meier, Christina
Ammon, Anna
Parker, Scott http://orcid.org/0000-0003-0364-4314
Wendland, Kerstin http://orcid.org/0000-0001-9776-5437
George, Rebekka http://orcid.org/0000-0003-4073-9179
Petkovic, Srdjan
Mellenthin, Lisa
Emmerich, Charlotte
Lutzny-Geier, Gloria http://orcid.org/0000-0002-9648-2635
Metzler, Markus
Mackensen, Andreas
Chandramohan, Vidyalakshmi
Müller, Fabian http://orcid.org/0000-0001-5487-5839
Funding for this research was provided by:
Deutsche Krebshilfe (0113695)
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Erlangen; Grant Reference Number: J59
Article History
Received: 4 July 2023
Revised: 1 August 2023
Accepted: 8 August 2023
First Online: 26 August 2023
Competing interests
: FM received research funds and honoraria from AstraZeneca and MedImmune. All other authors declare no conflict of interest.
: Patient samples were collected with informed consent and in accordance with the Helsinki declaration on approval from the Ethics Committee of the University of Erlangen-Nuremberg. All animal studies were approved by the the local regulatory agency (government of Unterfranken).